Evidence map›Paper›PMID 33794899›Full record

ReviewBiomedical engineering online2021

MXene in the lens of biomedical engineering: synthesis, applications and future outlook.

Adibah Zamhuri, Gim Pao Lim, Nyuk Ling Ma, Kian Sek Tee, Chin Fhong Soon

Abstract readReview
In one paragraph

Review in Biomedical engineering online, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed.

  1. NbRSC advances · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. MXene and prostate cancer: is there promising news?Nanomedicine (London, England) · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adibah ZamhuriBiosensor and Bioengineering Lab, Microelectronics and Nanotechnology-Shamsuddin Research Centre, Institute for Integrated Engineering, Universiti Tun Hussein Onn Malaysia, Parit Raja, 86400, Batu Pahat, Johor, Malaysia.
Gim Pao LimBiosensor and Bioengineering Lab, Microelectronics and Nanotechnology-Shamsuddin Research Centre, Institute for Integrated Engineering, Universiti Tun Hussein Onn Malaysia, Parit Raja, 86400, Batu Pahat, Johor, Malaysia.
Nyuk Ling MaFaculty of Science and Marine Environment, Universiti Malaysia Terengganu, 21030 Kuala Nerus, Terengganu, Malaysia.
Kian Sek TeeFaculty of Electrical and Electronic Engineering, Universiti Tun Hussein Onn Malaysia, Parit Raja, 86400, Batu Pahat, Johor, Malaysia.
Chin Fhong SoonBiosensor and Bioengineering Lab, Microelectronics and Nanotechnology-Shamsuddin Research Centre, Institute for Integrated Engineering, Universiti Tun Hussein Onn Malaysia, Parit Raja, 86400, Batu Pahat, Johor, Malaysia. soon@uthm.edu.my.ORCID http://orcid.org/0000-0002-4972-5729

Funding

Malaysia Ministry of Education FRGS/1/2018/STG05/UTHM/02/3
6 · The paper itself

Abstract

MXene is a recently emerged multifaceted two-dimensional (2D) material that is made up of surface-modified carbide, providing its flexibility and variable composition. They consist of layers of early transition metals (M), interleaved with n layers of carbon or nitrogen (denoted as X) and terminated with surface functional groups (denoted as T

Indexed as

Biomedical EngineeringAnimalsBiocompatible MaterialsCarbonChemistry Techniques, SyntheticHumansTantalumTitaniumBiocompatible MaterialsCarbonTantalumTitaniumtitanium carbideAntimicrobial activityBiomedical applicationBiosensorsCancer theranosticsDrug deliveryMXene

Identifiers

PMID33794899
PMCPMC8017618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.